Thrombolytic Science
Research - Cambridge, Massachusetts, United States
Thrombolytic Science Employees
Thrombolytic Science Details
TSI is a privately-held vascular medicine and biotechnology company currently developing a new-generation clot-dissolving therapy with the first novel mechanism of action in 20 years for stroke and other thrombotic diseases. TSI's technology is based upon pioneering earlier work on pro-urokinase (proUK) by its cofounders. The primary component of TSI's thrombolytic therapy is a rationally designed mutant of proUK.
Website:
http://www.tsillc.net
Employees:
3
HQ:
+1 617-661-1103
Location:
Cambridge, Massachusetts, United States
Revenue:
5.3M
Thrombolytic Science Technologies
Email Providers
Outlook
Load Balancers
Varnish
CMS
Wix
Other
Mobile Friendly
Hosting
Google Cloud Hosting